The simultaneous binding of NF-κB and of the R273H p53 mutant and other detected mutant forms of p53 in colorectal carcinomas regulates RNA polymerase II recruitment to these enhancers and facilitates mRNA synthesis and the activation of tumour-promoting genes like MMP9 and CCL2 [41]. The gene discussed is TP53; the disease is colorectal carcinoma.